Literature DB >> 15773879

Anxiety as a predictor of pain magnitude following termination of first-trimester pregnancy.

Dorit Pud1, Amnon Amit.   

Abstract

OBJECTIVE: The purpose of the study was to investigate anxiety and other factors that may predict pain magnitude following termination of pregnancy (TOP) during the first trimester.
DESIGN: Prospective, nonrandomized study.
SETTING: Department of Obstetrics and Gynecology, Rambam Medical Center in Haifa, Israel. PATIENTS: Forty consecutive women undergoing TOP. OUTCOME MEASURES: Women undergoing a TOP were asked to fill out the State-Trait Anxiety Inventory. Pain magnitude was measured by using a visual analog scale (VAS) at 15, 30, and 60 minutes following the procedure. Correlations between state anxiety, trait anxiety, age, parity, number of TOP, gestational age, and pain magnitude were measured.
RESULTS: State anxiety was able to predict pain magnitude on VAS 15 minutes after TOP (P = 0.023), and trait anxiety was able to predict pain magnitude on VAS 30 minutes after TOP (P = 0.013). Other variables failed to show significant results.
CONCLUSIONS: Preoperative assessment of anxiety levels may lead to appropriate treatment in order to alleviate discomfort and ensure pain control outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15773879     DOI: 10.1111/j.1526-4637.2005.05030.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

1.  Doula support during first-trimester surgical abortion: a randomized controlled trial.

Authors:  Julie Chor; Brandon Hill; Summer Martins; Stephanie Mistretta; Ashlesha Patel; Melissa Gilliam
Journal:  Am J Obstet Gynecol       Date:  2014-06-28       Impact factor: 8.661

Review 2.  Pain management for medical abortion before 14 weeks' gestation.

Authors:  John J Reynolds-Wright; Mulat A Woldetsadik; Chelsea Morroni; Sharon Cameron
Journal:  Cochrane Database Syst Rev       Date:  2022-05-13

3.  Experiences with pain of early medical abortion: qualitative results from Nepal, South Africa, and Vietnam.

Authors:  Daniel Grossman; Sarah Raifman; Tshegofatso Bessenaar; Lan Dung Duong; Anand Tamang; Monica V Dragoman
Journal:  BMC Womens Health       Date:  2019-10-15       Impact factor: 2.809

4.  Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.

Authors:  Justin J Chu; Adam J Devall; Leanne E Beeson; Pollyanna Hardy; Versha Cheed; Yongzhong Sun; Tracy E Roberts; C Okeke Ogwulu; Eleanor Williams; Laura L Jones; Jenny H La Fontaine Papadopoulos; Ruth Bender-Atik; Jane Brewin; Kim Hinshaw; Meenakshi Choudhary; Amna Ahmed; Joel Naftalin; Natalie Nunes; Abigail Oliver; Feras Izzat; Kalsang Bhatia; Ismail Hassan; Yadava Jeve; Judith Hamilton; Shilpa Deb; Cecilia Bottomley; Jackie Ross; Linda Watkins; Martyn Underwood; Ying Cheong; Chitra S Kumar; Pratima Gupta; Rachel Small; Stewart Pringle; Frances Hodge; Anupama Shahid; Ioannis D Gallos; Andrew W Horne; Siobhan Quenby; Arri Coomarasamy
Journal:  Lancet       Date:  2020-08-24       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.